Ardelyx tops off B round with $12.4 million

Ardelyx Inc. (Fremont, Calif.) raised an additional $12.4 million in a series B round, bringing the total raised in the round to $30 million. New Investor Amgen Ventures joined existing investors New Enterprise Associates and CMEA Capital in the round. Individual investors also participated.

Ardelyx also hired Mark Kaufmann to the newly created position of CBO. Kaufmann is the former president and CEO of now-defunct autoimmune company Allostera Pharma Inc. ...